Relation of aspirin response to age in patients with stable coronary artery disease

American Journal of Cardiology

Volumn 112, Issue 2, 2013, Pages 212-216

  Vaturi, Mordehay ^a   Vaduganathan, Muthiah ^b   Bental, Tamir ^a   Solodky, Alejandro ^a   Kornowski, Ran ^a   Lev, Eli I ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE;

AGE; AGED; ARTICLE; BODY MASS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG RESPONSE; FEMALE; HEART INFARCTION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASPIRIN; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS;

EID: 84879845847     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.03.022     Document Type: Article

References (27)

1. M.R. Buchanan, and S.J. Brister Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically Can J Cardiol 11 1995 221 227
2. J.W. Eikelboom, J. Hirsh, J.I. Weitz, M. Johnston, Q. Yi, and S. Yusuf Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 2002 1650 1655
3. P.A. Gum, K. Kottke-Marchant, E.D. Poggio, H. Gurm, P.A. Welsh, L. Brooks, S.K. Sapp, and E.J. Topol Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 88 2001 230 235
4. P.A. Gum, K. Kottke-Marchant, P.A. Welsh, J. White, and E.J. Topol A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 2003 961 965
5. E.I. Lev, R.T. Patel, K.J. Maresh, S. Guthikonda, J. Granada, T. DeLao, P.F. Bray, and N.S. Kleiman Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance J Am Coll Cardiol 47 2006 27 33
6. W.H. Chen, P.Y. Lee, W. Ng, H.F. Tse, and C.P. Lau Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment J Am Coll Cardiol 43 2004 1122 1126
7. W.H. Chen, X. Cheng, P.Y. Lee, W. Ng, J.Y. Kwok, H.F. Tse, and C.P. Lau Aspirin resistance and adverse clinical events in patients with coronary artery disease Am J Med 120 2007 631 635
8. U.S. Tantry, K.P. Bliden, and P.A. Gurbel Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation J Am Coll Cardiol 46 2005 1705 1709
9. J.W. Eikelboom, G.J. Hankey, J. Thom, D.L. Bhatt, P.G. Steg, G. Montalescot, S.C. Johnston, S.R. Steinhubl, K.H. Mak, J.D. Easton, C. Hamm, T. Hu, K.A. Fox, E.J. Topol CHARISMA Investigators Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk Circulation 118 2008 1705 1712
10. G. Krasopoulos, S.J. Brister, W.S. Beattie, and M.R. Buchanan Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis BMJ 336 2008 195 198
11. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
12. H.T. Sorensen, L. Mellemkjar, W.J. Blot, G.L. Nielsen, F.H. Steffensen, J.K. McLaughlin, and J.H. Olsen Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin Am J Gastroenterol 95 2000 2218 2224
13. S.R. Mehta, J.-F. Tanguay, J.W. Eikelboom, S.S. Jolly, C.D. Joyner, C.B. Granger, D.P. Faxon, H.J. Rupprecht, A. Budaj, A. Avezum, P. Widimsky, P.G. Steg, J.P. Bassand, G. Montalescot, C. Macaya, G. Di Pasquale, K. Niemela, A.E. Ajani, H.D. White, S. Chrolavicius, P. Gao, K.A. Fox, S. Yusuf CURRENT-OASIS 7 Trial Investigators Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
14. T. Cuisset, J. Quilici, C. Grosdidier, L. Fourcade, B. Gaborit, M. Pankert, L. Molines, P.E. Morange, J.L. Bonnet, and M.C. Alessi Comparison of platelet reactivity and clopidogrel response in patients ≤75 years versus >75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome Am J Cardiol 108 2011 1411 1416
15. T. Gremmel, S. Steiner, D. Seidinger, R. Koppensteiner, S. Panzer, and C.W. Kopp Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel J Thromb Haemost 8 2010 37 42
16. J. Silvain, G. Cayla, J.S. Hulot, J. Finzi, M. Kerneis, S.A. O'Connor, A. Bellemain-Appaix, O. Barthélémy, F. Beygui, J.P. Collet, and G. Montalescot High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study Eur Heart J 33 2012 1241 1249
17. M.A. Tidjane, S. Voisin, T. Lhermusier, V. Bongard, P. Sié, and D. Carrié More on: adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel J Thromb Haemost 9 2011 614 616
18. P.Y. Lee, W.H. Chen, W. Ng, X. Cheng, J.Y. Kwok, H.F. Tse, and C.P. Lau Low-dose aspirin increases aspirin resistance in patients with coronary artery disease Am J Med 118 2005 723 727
19. M. Vaduganathan, C.L. Alviar, M.E. Arikan, A. Tellez, S. Guthikonda, T. DeLao, J.F. Granada, N.S. Kleiman, C.M. Ballantyne, and E.I. Lev Platelet reactivity and response to aspirin in subjects with the metabolic syndrome Am Heart J 156 2008 e1001 e1007
20. A.L. Frelinger III, M.I. Furman, M.D. Linden, Y. Li, M.L. Fox, M.R. Barnard, and A.D. Michelson Residual arachidonic acid-induced platelet activation via an adenosine diphosphate dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance Circulation 113 2006 2888 2896
21. D. Mari, R. Coppola, and R. Provenzano Hemostasis factors and aging Ext Gerontol 43 2008 66 73
22. I. Goubareva, E. Gkaliagkousi, A. Shah, L. Queen, J. Ritter, and A. Ferro Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates Cardiovasc Res 75 2007 793 802
23. F. Cesari, R. Marcucci, R. Caporale, R. Paniccia, E. Romano, G.F. Gensini, R. Abbate, and A.M. Gori Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy Thromb Haemost 99 2008 930 935
24. Antithrombotic Trialists' (ATT) Collaboration Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
25. K.P. Alexander, L.K. Newby, P.W. Armstrong, C.P. Cannon, W.B. Gibler, M.W. Rich, F. Van de Werf, H.D. White, W.D. Weaver, M.D. Naylor, J.M. Gore, H.M. Krumholz, E.M. Ohman American Heart Association Council on Clinical Cardiology, Society of Geriatric Cardiology Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2007 2570 2589
26. K.P. Alexander, L.K. Newby, C.P. Cannon, P.W. Armstrong, W.B. Gibler, M.W. Rich, F. Van de Werf, H.D. White, W.D. Weaver, M.D. Naylor, J.M. Gore, H.M. Krumholz, E.M. Ohman American Heart Association Council on Clinical Cardiology, Society of Geriatric Cardiology Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2007 2549 2569
27. J. Cao, L. Liu, L. Fan, T. Chen, G. Hu, Y. Hu, B. Zhu, J. Li, H. Wang, and X. Li The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease Aging Male 15 2012 140 147